Study of ASN51 in Adults With Early Alzheimer's Disease

NCT06677203 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

123

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic decision

Conditions

Alzheimer Disease

Interventions

DRUG: ASN51
DRUG: Placebo

Sponsor

Asceneuron S.A.